Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende Patientenratgeber
Erweiterte Suche
Anmelden
nach oben
Clinical Oral Investigations
Erschienen in:

22.07.2017 | Original Article

Comparative metabolic analysis in head and neck cancer and the normal gingiva

verfasst von: Nadine Fabienne Voelxen, Sebastian Blatt, Pascal Knopf, Maurice Henkel, Christina Appelhans, Leonardo A. R. Righesso, Andreas Pabst, Jutta Goldschmitt, Stefan Walenta, Andreas Neff, Wolfgang Mueller-Klieser, Thomas Ziebart

Erschienen in: Clinical Oral Investigations | Ausgabe 2/2018

Einloggen, um Zugang zu erhalten

Abstract

Objectives

Chronic accumulation of lactate in malignant tumor tissue is associated with increased malignancy and radioresistance. For this study, biopsies of primary head and neck squamous cell carcinoma (HNSCC) and of the normal gingiva of the same patient were compared via metabolic profiling to the healthy gingiva from cancer-free patients.

Materials and methods

Cryobiopsies of 140 HNSCC patients were used to determine ATP, lactate, and glucose concentrations of the tumor and normal gingiva via induced metabolic bioluminescence imaging (imBI). Additionally, these metabolites were quantified in a collective of 79 healthy (non-tumor-bearing) patients. Furthermore, tumor samples were analyzed via immunofluorescence imaging and quantitative real-time PCR for the expression of lactate and glucose transporters.

Results

There were significant differences in ATP concentrations detectable between the tumor, normal gingiva of tumor patients, and gingiva from healthy patients. Lactate concentrations were significantly increased in tumor tissue compared to the normal gingiva of tumor patients as well as the gingiva from healthy patients. Concerning glucose, there was a significant decrease in glucose concentrations detectable in the tumor biopsies compared to the normal gingiva of tumor patients. On the other hand, tumor samples from patients revealed significantly elevated relative expression levels of monocarboxylate transporters (MCT-1 and MCT-4), as well as glucose transporters (GLUT-1 and GLUT-3) compared to the corresponding normal gingiva of each patient.

Conclusions

We could demonstrate that the lactate concentration in HNSCC correlates with primary tumor (T) stage.

Clinical relevance

The aim of this study was to identify metabolic parameters to improve early cancer diagnosis, allow predictions on the degree of malignancy, and contribute to a personalized tumor therapy.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Argiris A, Karamouzis MV, Raben D, Ferris RL (2008) Head and neck cancer. Lancet 371:1695–1709CrossRefPubMed
2.
Reichart PA (2000) Primary prevention of mouth carcinoma and oral precancerous conditions. Mund Kiefer Gesichtschir 4:357–364CrossRefPubMed
3.
Aruna DS, Prasad KV, Shavi GR, Ariga J, Rajesh G, Krishna M (2011) Retrospective study on risk habits among oral cancer patients in Karnataka Cancer Therapy and Research Institute, Hubli. India Asian Pac J Cancer Prev 12:1561–1566PubMed
4.
J.M. Hirsch, M. Wallstrom, A.P. Carlsson, and L. Sand, Oral cancer in Swedish snuff dippers Anticancer Res 32, 3327–3330 (2012)
5.
Spitz MR (1994) Epidemiology and risk factors for head and neck cancer. Semin Oncol 21:281–288PubMed
6.
Zheng TZ, Boyle P, Hu HF, Duan J, Jian PJ, Ma DQ, Shui LP, Niu SR, Scully C, MacMahon B (1990) Dentition, oral hygiene, and risk of oral cancer: a case-control study in Beijing People's Republic of China. Cancer Causes Control 1:235–241CrossRefPubMed
7.
Kreimer AR, Clifford GM, Boyle P, Franceschi S (2005) Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev 14:467–475CrossRefPubMed
8.
Smith EM, Rubenstein LM, Haugen TH, Pawlita M, Turek LP (2012) Complex etiology underlies risk and survival in head and neck cancer human papillomavirus, tobacco, and alcohol: a case for multifactor disease. J Oncol 2012:571862CrossRefPubMedPubMedCentral
9.
Kroemer G, Pouyssegur J (2008) Tumor cell metabolism: cancer's Achilles' heel. Cancer Cell 13:472–482CrossRefPubMed
10.
Walenta S, Mueller-Klieser WF (2004) Lactate: mirror and motor of tumor malignancy. Semin Radiat Oncol 14:267–274CrossRefPubMed
11.
Walenta S, Wetterling M, Lehrke M, Schwickert G, Sundfor K, Rofstad EK, Mueller-Klieser W (2000) High lactate levels predict likelihood of metastases, tumor recurrence, and restricted patient survival in human cervical cancers. Cancer Res 60:916–921PubMed
12.
Brizel DM, Schroeder T, Scher RL, Walenta S, Clough RW, Dewhirst MW, Mueller-Klieser W (2001) Elevated tumor lactate concentrations predict for an increased risk of metastases in head-and-neck cancer. Int J Radiat Oncol Biol Phys 51:349–353CrossRefPubMed
13.
Walenta S, Chau TV, Schroeder T, Lehr HA, Kunz-Schughart LA, Fuerst A, Mueller-Klieser W (2003) Metabolic classification of human rectal adenocarcinomas: a novel guideline for clinical oncologists? J Cancer Res Clin Oncol 129:321–326CrossRefPubMed
14.
15.
Sattler UG, Meyer SS, Quennet V, Hoerner C, Knoerzer H, Fabian C, Yaromina A, Zips D, Walenta S, Baumann M, Mueller-Klieser W (2010) Glycolytic metabolism and tumour response to fractionated irradiation Radiother. Oncologia 94:102–109
16.
Halestrap AP (2012) The monocarboxylate transporter family—structure and functional characterization. IUBMB Life 64:1–9CrossRefPubMed
17.
Fang J, Quinones QJ, Holman TL, Morowitz MJ, Wang Q, Zhao H, Sivo F, Maris JM, Wahl ML (2006) The H+-linked monocarboxylate transporter (MCT1/SLC16A1): a potential therapeutic target for high-risk neuroblastoma. Mol Pharmacol 70:2108–2115CrossRefPubMed
18.
Pinheiro C, Albergaria A, Paredes J, Sousa B, Dufloth R, Vieira D, Schmitt F, Baltazar F (2010) Monocarboxylate transporter 1 is up-regulated in basal-like breast carcinoma. Histopathology 56:860–867CrossRefPubMed
19.
Pinheiro C, Reis RM, Ricardo S, Longatto-Filho A, Schmitt F, Baltazar F (2010) Expression of monocarboxylate transporters 1, 2, and 4 in human tumours and their association with CD147 and CD44. J Biomed. Biotechnol 2010:427694CrossRefPubMedPubMedCentral
20.
Medina RA, Owen GI (2002) Glucose transporters: expression, regulation and cancer. Biol Res 35:9–26CrossRefPubMed
21.
Joost HG, Thorens B (2001) The extended GLUT-family of sugar/polyol transport facilitators: nomenclature, sequence characteristics, and potential function of its novel members (review). Mol Membr Biol 18:247–256CrossRefPubMed
22.
Wood IS, Trayhurn P (2003) Glucose transporters (GLUT and SGLT): expanded families of sugar transport proteins. Br J Nutr 89:3–9CrossRefPubMed
23.
Kasahara M, Hinkle PC (1977) Reconstitution and purification of the D-glucose transporter from human erythrocytes. J Biol Chem 252:7384–7390PubMed
24.
Alo PL, Visca P, Botti C, Galati GM, Sebastiani V, Andreano T, Di TU, Pizer ES (2001) Immunohistochemical expression of human erythrocyte glucose transporter and fatty acid synthase in infiltrating breast carcinomas and adjacent typical/atypical hyperplastic or normal breast tissue. Am J Clin Pathol 116:129–134CrossRefPubMed
25.
Godoy A, Ulloa V, Rodriguez F, Reinicke K, Yanez AJ, Garcia ML, Medina RA, Carrasco M, Barberis S, Castro T, Martinez F, Koch X, Vera JC, Poblete MT, Figueroa CD, Peruzzo B, Perez F, Nualart F (2006) Differential subcellular distribution of glucose transporters GLUT1-6 and GLUT9 in human cancer: ultrastructural localization of GLUT1 and GLUT5 in breast tumor tissues. J Cell Physiol 207:614–627CrossRefPubMed
26.
Harshani JM, Yeluri S, Guttikonda VR (2014) Glut-1 as a prognostic biomarker in oral squamous cell carcinoma. J Oral Maxillofac Pathol 18:372–378CrossRefPubMedPubMedCentral
27.
Higashi T, Tamaki N, Honda T, Torizuka T, Kimura T, Inokuma T, Ohshio G, Hosotani R, Imamura M, Konishi J (1997) Expression of glucose transporters in human pancreatic tumors compared with increased FDG accumulation in PET study. J Nucl Med 38:1337–1344PubMed
28.
Marom EM, Aloia TA, Moore MB, Hara M, Herndon JE, Harpole DH Jr, Goodman PC, Patz EF Jr (2001) Correlation of FDG-PET imaging with Glut-1 and Glut-3 expression in early-stage non-small cell lung cancer. Lung Cancer 33:99–107CrossRefPubMed
29.
Mellanen P, Minn H, Grenman R, Harkonen P (1994) Expression of glucose transporters in head-and-neck tumors. Int J Cancer 56:622–629CrossRefPubMed
30.
Ziebart T, Walenta S, Kunkel M, Reichert TE, Wagner W, Mueller-Klieser W (2011) Metabolic and proteomic differentials in head and neck squamous cell carcinomas and normal gingival tissue. J Cancer Res Clin Oncol 137:193–199CrossRefPubMed
31.
Mueller-Klieser W, Walenta S (1993) Geographical mapping of metabolites in biological tissue with quantitative bioluminescence and single photon imaging. Histochem J 25:407–420CrossRefPubMed
32.
Walenta S, Schroeder T, Mueller-Klieser W (2004) Lactate in solid malignant tumors: potential basis of a metabolic classification in clinical oncology. Curr Med Chem 11:2195–2204CrossRefPubMed
33.
Walenta S, Voelxen NF, Sattler UGA, Mueller-Klieser W (2014) Localizing and quantifying metabolites in situ with luminometry: induced metabolic bioluminescence imaging (imBI). Neuromethods 90:195–216CrossRef
34.
Kanekura T, Chen X (2010) CD147/basigin promotes progression of malignant melanoma and other cancers. J Dermatol Sci 57:149–154CrossRefPubMed
35.
Kunkel M, Reichert TE, Benz P, Lehr HA, Jeong JH, Wieand S, Bartenstein P, Wagner W, Whiteside TL (2003) Overexpression of Glut-1 and increased glucose metabolism in tumors are associated with a poor prognosis in patients with oral squamous cell carcinoma. Cancer 97:1015–1024CrossRefPubMed
36.
J.M. Curry, M. Tuluc, D. Whitaker-Menezes, J.A. Ames, A. Anantharaman, A. Butera, B. Leiby, D.M. Cognetti, F. Sotgia, M.P. Lisanti, and U.E. Martinez-Outschoorn, Cancer metabolism, stemness and tumor recurrence: MCT1 and MCT4 are functional biomarkers of metabolic symbiosis in head and neck cancer Cell Cycle 12, 1371–1384 (2013)
37.
Z.J. Sun, G.T. Yu, C.F. Huang, L.L. Bu, J.F. Liu, S.R. Ma, W.F. Zhang, B. Liu, and L. Zhang, (2016) Hypoxia induce TFE3 expression in head and neck squamous cell carcinoma Oncotarget
38.
Walenta S, Salameh A, Lyng H, Evensen JF, Mitze M, Rofstad EK, Mueller-Klieser W (1997) Correlation of high lactate levels in head and neck tumors with incidence of metastasis. Am J Pathol 150:409–415PubMedPubMedCentral
39.
S. Blatt, N. Voelxen, K. Sagheb, A.M. Pabst, S. Walenta, T. Schroeder, W. Mueller-Klieser, and T. Ziebart, (2016) Lactate as a predictive marker for tumor recurrence in patients with head and neck squamous cell carcinoma (HNSCC) post radiation: a prospective study over 15 years Clinical Oral Investigations [ahead of print]
Metadaten
Titel
Comparative metabolic analysis in head and neck cancer and the normal gingiva
verfasst von
Nadine Fabienne Voelxen
Sebastian Blatt
Pascal Knopf
Maurice Henkel
Christina Appelhans
Leonardo A. R. Righesso
Andreas Pabst
Jutta Goldschmitt
Stefan Walenta
Andreas Neff
Wolfgang Mueller-Klieser
Thomas Ziebart
Publikationsdatum
22.07.2017
Verlag
Springer Berlin Heidelberg
Erschienen in
Clinical Oral Investigations / Ausgabe 2/2018
Print ISSN: 1432-6981
Elektronische ISSN: 1436-3771
DOI
https://doi.org/10.1007/s00784-017-2185-0

Weitere Artikel der Ausgabe 2/2018

The effects of ozone application on genotoxic damage and wound healing in bisphosphonate-applied human gingival fibroblast cells

  • Original Article

Does professional experience save teeth? A survey among prosthodontists

  • Original Article

Clinical evaluation of zirconia-based all-ceramic single crowns: an up to 12-year retrospective cohort study

  • Original Article

Influence of radiotherapy on the dentin properties and bond strength

  • Original Article

3D imaging, 3D printing and 3D virtual planning in endodontics

  • Review

Effectiveness for dentin hypersensitivity treatment of non-carious cervical lesions: a meta-analysis

  • Review

Neu im Fachgebiet Zahnmedizin

Endodontie kann Herzerkrankungsrisiko senken

Die Verbindung zwischen endodontischen Erkrankungen und koronaren Herzerkrankungen (KHK) rückt zunehmend in den Fokus der Forschung. Die Deutsche Gesellschaft für Zahn-, Mund- und Kieferheilkunde (DGZMK) hat aktuell zusammen mit der Deutschen Gesellschaft für Endodontologie und zahnärztliche Traumatologie (DGET) den Forschungsstand kurzgefasst veröffentlicht.

Das alles ändert sich für Arztpraxen in 2025

  • 31.12.2024
  • EBM
  • Nachrichten

Ab Januar greifen jede Menge Neuerungen – ob im EBM, Arbeits- und Steuerrecht oder bei der digitalen Vernetzung. Darunter einige Verbesserungen, aber teils auch Mehraufwand. „Same procedure as every year?“ – Ein Überblick.

Wenn Praxen Termine absagen müssen: So geht’s ohne Ärger und Stress

Bundesweit sind viele Praxen von Krankheitsfällen in den eigenen Reihen betroffen. Die Praxis-EDV und strukturierte Abläufe können notwendige Terminabsagen erleichtern.

Wie gefährlich sind suspekte Veränderungen in der Mundhöhle?

Wie hoch ist das Risiko, dass sich aus einer bereits verdächtigen Veränderung der Mundschleimhaut ein Karzinom entwickelt? Ein US-Team hat dazu das Patientenregister der Universität San Francisco ausgewertet.

Update Zahnmedizin

Bestellen Sie unseren kostenlosen Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.

Newsletter bestellen
Bildnachweise